Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Europe (Primary) | PRIMARYEUR | Univ | 6,371 | 19,127,172 | 0.30% | -1.01% | -1.54% | 0.76% | 8.62% | 6.39% |
Healthcare | HEALTHCARE | Sector | 581 | 2,142,834 | -0.67% | -3.74% | 0.18% | -2.72% | -3.13% | -12.85% |
Biopharmaceuticals | BIOPHARMA | SubSec | 187 | 1,649,686 | -0.97% | -4.56% | 0.49% | -3.76% | -4.27% | -15.67% |
Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 58 | 58,267 | -0.92% | -4.82% | -0.57% | 0.37% | -6.35% | -11.94% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 13 | 3,742 | 0.04% | -5.24% | 1.45% | 1.74% | -3.45% | -3.92% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 724 | -2.10% | -4.40% | 9.16% | 0.62% | 20.17% | 17.15% |
Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 2,092 | 0.17% | -5.30% | 4.72% | 4.85% | -12.99% | 10.05% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 13 | 3,742 | 0.04% | -5.24% | 1.45% | 1.74% | -3.45% | -3.92% |
Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,371 | 19,127,172 | 0.12% | -1.56% | -2.29% | -1.02% | 8.08% | 6.69% |
* Colors indicate performance relative to the benchmark.